NL182565C - 1-oxo-1h-thiazolo(3,2-a)pyrimidine-2-carbonzuurderivaat met antiallergische en/of antimaagzuurwerking en farmaceutisch voorwerp, dat een dergelijke verbinding bevat. - Google Patents

1-oxo-1h-thiazolo(3,2-a)pyrimidine-2-carbonzuurderivaat met antiallergische en/of antimaagzuurwerking en farmaceutisch voorwerp, dat een dergelijke verbinding bevat.

Info

Publication number
NL182565C
NL182565C NLAANVRAGE8006362,A NL8006362A NL182565C NL 182565 C NL182565 C NL 182565C NL 8006362 A NL8006362 A NL 8006362A NL 182565 C NL182565 C NL 182565C
Authority
NL
Netherlands
Prior art keywords
thiazolo
allergic
pyrimidine
oxo
compound
Prior art date
Application number
NLAANVRAGE8006362,A
Other languages
English (en)
Dutch (nl)
Other versions
NL8006362A (nl
NL182565B (nl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL8006362A publication Critical patent/NL8006362A/nl
Publication of NL182565B publication Critical patent/NL182565B/xx
Application granted granted Critical
Publication of NL182565C publication Critical patent/NL182565C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NLAANVRAGE8006362,A 1979-11-23 1980-11-21 1-oxo-1h-thiazolo(3,2-a)pyrimidine-2-carbonzuurderivaat met antiallergische en/of antimaagzuurwerking en farmaceutisch voorwerp, dat een dergelijke verbinding bevat. NL182565C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9663179A 1979-11-23 1979-11-23
US9663179 1979-11-23

Publications (3)

Publication Number Publication Date
NL8006362A NL8006362A (nl) 1981-06-16
NL182565B NL182565B (nl) 1987-11-02
NL182565C true NL182565C (nl) 1988-04-05

Family

ID=22258306

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE8006362,A NL182565C (nl) 1979-11-23 1980-11-21 1-oxo-1h-thiazolo(3,2-a)pyrimidine-2-carbonzuurderivaat met antiallergische en/of antimaagzuurwerking en farmaceutisch voorwerp, dat een dergelijke verbinding bevat.

Country Status (35)

Country Link
JP (1) JPS5687586A (cs)
KR (1) KR830004322A (cs)
AR (2) AR228859A1 (cs)
AT (1) AT380883B (cs)
AU (1) AU520995B2 (cs)
BE (1) BE886319A (cs)
CA (1) CA1143731A (cs)
CH (1) CH649299A5 (cs)
CS (1) CS241476B2 (cs)
DD (1) DD154608A5 (cs)
DE (2) DE3043979C2 (cs)
DK (1) DK151811C (cs)
EG (1) EG14929A (cs)
ES (1) ES8203363A1 (cs)
FI (1) FI67706C (cs)
FR (1) FR2470132A1 (cs)
GB (1) GB2063862B (cs)
GR (1) GR72132B (cs)
GT (1) GT198066458A (cs)
HU (1) HU179091B (cs)
IE (1) IE50404B1 (cs)
IL (1) IL61535A (cs)
IN (1) IN154926B (cs)
IT (1) IT1209373B (cs)
LU (1) LU82950A1 (cs)
NL (1) NL182565C (cs)
NO (1) NO803521L (cs)
NZ (1) NZ195596A (cs)
PH (1) PH16666A (cs)
PL (1) PL132354B1 (cs)
PT (1) PT72090B (cs)
SE (1) SE448732B (cs)
SU (1) SU1042620A3 (cs)
YU (1) YU41953B (cs)
ZA (1) ZA807293B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
JP2690742B2 (ja) * 1987-03-30 1997-12-17 第一製薬株式会社 複素環アミン誘導体
DE68926473T2 (de) * 1988-03-28 1996-10-02 Janssen Pharmaceutica Nv Mittel zur Konservierung oder Wiederherstellung der gesunden Haut
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1331059A (en) * 1971-04-19 1973-09-19 Lilly Industries Ltd Pyrimidotriazinone compounds
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
DE2810863A1 (de) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones

Also Published As

Publication number Publication date
PT72090A (en) 1980-12-01
FI67706B (fi) 1985-01-31
FR2470132A1 (fr) 1981-05-29
DE3043979A1 (de) 1981-09-03
PL132354B1 (en) 1985-02-28
ZA807293B (en) 1981-12-30
PL228008A1 (cs) 1981-12-11
IL61535A (en) 1984-06-29
IE50404B1 (en) 1986-04-16
CH649299A5 (fr) 1985-05-15
DK413180A (da) 1981-05-24
FI803628L (fi) 1981-05-24
AR231296A1 (es) 1984-10-31
DK151811B (da) 1988-01-04
NL8006362A (nl) 1981-06-16
CS782080A2 (en) 1985-06-13
DD154608A5 (de) 1982-04-07
GT198066458A (es) 1982-05-15
CA1143731A (en) 1983-03-29
AT380883B (de) 1986-07-25
NO803521L (no) 1981-05-25
GR72132B (cs) 1983-09-19
IN154926B (cs) 1984-12-22
SE448732B (sv) 1987-03-16
KR830004322A (ko) 1983-07-09
SU1042620A3 (ru) 1983-09-15
IT8026176A0 (it) 1980-11-21
HU179091B (en) 1982-08-28
FI67706C (fi) 1985-05-10
YU41953B (en) 1988-02-29
AR228859A1 (es) 1983-04-29
SE8008189L (sv) 1981-05-24
PT72090B (en) 1981-09-29
LU82950A1 (fr) 1981-06-04
ES497066A0 (es) 1982-04-01
IT1209373B (it) 1989-07-16
GB2063862A (en) 1981-06-10
GB2063862B (en) 1983-06-22
IE802418L (en) 1981-05-23
DE3050491C2 (de) 1985-10-10
YU295080A (en) 1983-06-30
PH16666A (en) 1983-12-13
CS241476B2 (en) 1986-03-13
ATA570780A (de) 1985-12-15
EG14929A (en) 1989-01-30
IL61535A0 (en) 1980-12-31
JPS617432B2 (cs) 1986-03-06
BE886319A (fr) 1981-05-25
FR2470132B1 (cs) 1983-07-29
AU6459580A (en) 1981-05-28
ES8203363A1 (es) 1982-04-01
DE3043979C2 (de) 1986-08-21
NZ195596A (en) 1984-05-31
AU520995B2 (en) 1982-03-11
NL182565B (nl) 1987-11-02
DK151811C (da) 1988-06-06
JPS5687586A (en) 1981-07-16

Similar Documents

Publication Publication Date Title
DK343980A (da) 2,4,6-triiod-isophthalsyrederivater
DK343880A (da) 2,4,6-triiod-isophthalsyrederivater
DE3069559D1 (en) Beta-carbolin-3-carboxylic acid derivatives, pharmaceutical compositions containing them and their therapeutical use
NL190702B (nl) 4h-pyrido(1,2-a)pyrimidin-4-on verbinding met anti-allergische werkzaamheid, alsmede farmaceutisch preparaat daarvan.
ATE37028T1 (de) Cephalosporinverbindungen, ihre herstellung, pharmazeutische praeparate und eingangsprodukte.
NL183358C (nl) Farmaceutisch preparaat, en daarin te gebruiken penicillaanzuur-derivaat met beta-lactamase-remmende werking.
NL970028I1 (nl) 2(1H)-Pyridinonderivaten en farmaceutische preparaten die deze derivaten bevatten.
PL198404A1 (pl) Srodek chwastobojczy,zawierajacy pochodne kwasu fenoksyfenoksypropionowego oraz sposobu wytwarzania tych zwiazkow
JPS56164185A (en) Imidazole derivative, its manufacture and drug thereof
GB1532140A (en) Azolylcarboxylic acid derivatives and their use as fungicides
NO890512L (no) Artikkelemballasje av hylsetypen.
NL190662C (nl) alfa-Halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat dat dit bevat.
PH19005A (en) Penicillanic acid derivatives,pharmaceutical compositions containing the same and method of use thereof
IL52493A (en) 1,2-dihydro-5-benzoyl-3h-pyrrolo(1,2-a)pyrrole-1-carboxylic acid derivatives,their production and pharmaceutical compositions containing them
JPS5661374A (en) Cytostatic drug* novel cyanuric acid derivative and manufacture thereof
NL192741B (nl) Oxazafosforin-4-thioalkaanzuurverbindingen en farmaceutisch preparaat met antineoplastische eigenschappen.
NO803592L (no) 4,5-umettede prostansyre-derivater.
NL182565B (nl) 1-oxo-1h-thiazolo(3,2-a)pyrimidine-2-carbonzuurderivaat met antiallergische en/of antimaagzuurwerking en farmaceutisch voorwerp, dat een dergelijke verbinding bevat.
ATE2524T1 (de) Phenyliminothiazolinderivate, ihre herstellung und zwischenprodukte dafuer, sie enthaltende pharmazeutische praeparate und deren herstellung.
ATE32882T1 (de) Phenylnonatetraensaeurederivate, ihre herstellung und pharmazeutische praeparate mit diesen derivaten.
IT1186667B (it) 2,1,3-benzotiadiazoli e 2,1,3-benzossadiazoli,loro preparazione e loro applicazione come medicamenti
IL52492A (en) 5-furoyl-and 5-thenoyl-3h-pyrrolo(1,2-a)pyrrole-1-carboxylic acid derivatives,their production and pharmaceutical compositions containing them
JPS5377073A (en) Piperadine derivative compound and its production and medical drugs containing said compound
OA06795A (fr) N, N'-bis -(3-picolyl) -4-méthoxy-isophtalamide monohydratée et sa préparation.
IL66472A0 (en) Phenoxyphenylamino acid derivatives,their production and their use as herbicides

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BK Erratum

Free format text: CORRECTION TO PAMPHLET

V1 Lapsed because of non-payment of the annual fee